Ind-Swift Ltd exports its products to more than 50 countries with the help of Global Business Unit (GBU) which started operation in 2007.

The GBU Facility is compliant to the GMP specifications of MHRA (UK), TGA (Australia). It has got approval of various drug authorities as:

           » WHO (Geneva).

           » MOH (UAE).

           » TFDA (Tanzania).

           » NDA (Uganda).

           » DACA(Ethiopia)

           » Dar-Al- Dawa DAD (Jordan)

           » ITOCHU (Japan)

We develop and out license our products to UK, Europe, Canada, Australia with leading generic partners such as TEVA, Mylan, Actavis, Stada, Ratiopharm.
We have filed more than 680 dossiers in several countries.
Presently Business Negotiations are under process in Russia, Philippines, Taiwan, Afghanistan, Malaysia,
Costa Rica , Panama , Honduras , Venezuela , Peru , Guyana , Jamaica , Serbia.
We are also involved in CRAMS( Contract Research & Manufacturing Services).